Harvard Bioscience Inc (HBIO) Event Aug. 04, 2022, 11:01 UTC 18 1 comments (97% Positive) HARVARD BIOSCIENCE, INC. (HBIO) Reports Q3 2022 Financial Results Comment Full text
Compugen Ltd (CGEN) Event Aug. 04, 2022, 11:00 UTC 15 1 comments (30% Negative) Compugen Ltd (CGEN) Reports Q2 2022 Financial Results (Form 6-K) Comment Full text
Immunic Inc (IMUX) Event Aug. 04, 2022, 10:45 UTC 18 1 comments (70% Positive) IMMUNIC, INC. (IMUX) Reports Q3 2022 Financial Results Comment Full text
SpringWorks Therapeutics (SWTX) Event Aug. 04, 2022, 10:41 UTC 18 1 comments (10% Negative) SPRINGWORKS THERAPEUTICS, INC. (SWTX) Announces Delay in results Trials for multiple myeloma Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review Comment Full text
Madrigal Pharmaceuticals Inc (MDGL) Event Aug. 04, 2022, 10:33 UTC 18 1 comments (10% Negative) MADRIGAL PHARMACEUTICALS, INC. (MDGL) Reports Q3 2022 Financial Results Comment Full text
Aurinia Pharmaceuticals Inc (AUPH) Event Aug. 04, 2022, 10:07 UTC 18 1 comments (30% Negative) Aurinia Pharmaceuticals Inc. (AUPH) Reports Q3 2022 Financial Results Comment Full text
AstraZeneca (AZN) Event Aug. 04, 2022, 10:02 UTC 14 1 comments (90% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Comment Full text
Moderna Inc (MRNA) Event Aug. 04, 2022, 09:59 UTC 98 0 comments Moderna - Annual R&D Day 2022 Comment Full text
Rain Therapeutics Inc. (RAIN) Event Aug. 04, 2022, 05:01 UTC 96 0 comments Rain Therapeutics Announces Completion of Enrollment in Phase 3 MANTRA Trial for Milademetan in Liposarcoma Comment Full text
Cytokinetics Inc (CYTK) Event Aug. 04, 2022, 04:32 UTC 95 0 comments Cytokinetics and The ALS Association Announce Release of Updated PRO-ACT Database Including Data From Cytokinetics’ Completed ALS Clinical Trials Comment Full text